Hepln-13 is a potent and orally active Hepsin inhibitor with an IC50 of 0.33 µM. Hepln-13 can be used for the research of metastatic prostate cancer[1].
Molecular Weight:
325.20
Purity:
99.34
CAS Number:
[64369-13-7]
Formula:
C17H13BrN2
Target:
Ser/Thr Protease
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
